PMTS(PMTS)
PMTS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $593M | $645M |
| Low | $591M | $622M |
| High | $594M | $668M |
| EBITDA Avg | $104M | $113M |
| Low | $104M | $109M |
| High | $104M | $117M |
| EBIT Avg | $82M | $89M |
| Low | $82M | $86M |
| High | $82M | $93M |
| Net Income Avg | $28M | $37M |
| Low | $27M | $36M |
| High | $29M | $38M |
| EPS Avg | $2.33 | $3.06 |
| Low | $2.27 | $2.98 |
| High | $2.41 | $3.16 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $146M | $156M | $158M | $155M | $155M | $168M |
| Low | $142M | $152M | $153M | $150M | $151M | $163M |
| High | $149M | $161M | $163M | $159M | $160M | $173M |
| EBITDA Avg | $26M | $27M | $28M | $27M | $27M | $29M |
| Low | $25M | $27M | $27M | $26M | $26M | $29M |
| High | $26M | $28M | $29M | $28M | $28M | $30M |
| EBIT Avg | $20M | $22M | $22M | $21M | $22M | $23M |
| Low | $20M | $21M | $21M | $21M | $21M | $23M |
| High | $21M | $22M | $23M | $22M | $22M | $24M |
| Net Income Avg | $8M | $11M | $6M | $6M | $7M | $15M |
| Low | $8M | $11M | $6M | $6M | $6M | $14M |
| High | $8M | $12M | $6M | $6M | $7M | $16M |
| EPS Avg | $0.66 | $0.95 | $0.53 | $0.53 | $0.55 | $1.26 |
| Low | $0.64 | $0.91 | $0.51 | $0.51 | $0.53 | $1.21 |
| High | $0.69 | $0.98 | $0.55 | $0.55 | $0.57 | $1.31 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |